{"id":"NCT00765063","sponsor":"Pfizer","briefTitle":"The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)","officialTitle":"A 6 Month, Prospective, Open-Label Multiple Center Extension Trial To Evaluate The Long Term Safety And Sustained Efficacy Of Fragmin In The Treatment Of Chronic Foot Ulcers In Diabetic Patients With Peripheral Arterial Occlusive Disease","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-10","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2008-10-02","resultsPosted":"2012-01-13","lastUpdate":"2012-01-13"},"enrollment":62,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Foot Ulcer"],"interventions":[{"type":"DRUG","name":"Fragmin","otherNames":["Dalteparin sodium"]}],"arms":[{"label":"Active","type":"EXPERIMENTAL"}],"summary":"The primary objective of this 6 month open-label extension trial is to evaluate long-term safety and tolerability of dalteparin in treatment of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arterial occlusive disease (PAOD) and peripheral neuropathy.","primaryOutcome":{"measure":"Number of All Hemorrhages","timeFrame":"Baseline to Week 24 (end of treatment [EOT]) or early termination (ET)","effectByArm":[{"arm":"Dalteparin","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":27,"countries":["Austria","Belgium","Canada","Czechia","Denmark","Germany","Greece","Italy","Norway","Poland","Russia","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6301086&StudyName=The%20Effect%20Of%20Fragmin%20In%20The%20Treatment%20Of%20Neuroischaemic%20Foot%20Ulcers%20In%20Diabetic%20Patients%20%28A6301086%29"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":62},"commonTop":["Nasopharyngitis","Skin ulcer","Diabetic foot infection","Cardiac failure","Diarrhoea"]}}